Maralixibat

Overview

Maralixibat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL363392).

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Maralixibat expires 4 Oct 2043 and exclusivity 23 Jul 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-4-ol

Canonical SMILES

CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC

InChIKey

STPKWKPURVSAJF-LJEWAXOPSA-N